• 19 Feb 2019

LIBERUM: UK Small & Mid Cap Dispatches

Shield Therapeutics, 164 | SEGRO, 916 | Spectris, 2,820 | Big Yellow Group, 1,180 | FirstGroup, 126 | Go-Ahead Group, 2,042

    • Liberum Research Team

    • 5 pages

Stock Image


 
Stock Image


This content is only available within our institutional offering.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here

More Content

More Content

Taking on China

Companies: Shield Therapeutics

Shield Therapeutics' Feraccru drug 'a potential game-changer' - Capital Network Analyst

Companies: Shield Therapeutics

Shield Therapeutics - Feraccru out-licensed in China

Companies: Shield Therapeutics

Bitesize briefing - Shield Therapeutics

Companies: Shield Therapeutics

Shield Therapeutics ties up US$63mln deal for Feraccru in China

Companies: Shield Therapeutics

Copyright © 2020 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Tools licensed and contents implemented and optimized by Digital Look Ltd.

DigitalLook |Web Financial Group

©1999-2013 – Digital Look Ltd. A Web Financial Group Company All rights reserved. Legal notice.

Top